Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,488 total articles
Abbott Laboratories (ABT) plunged to a 52-week low today, trading near $94.48 after a sharp move lower. Fundamentals remain intact: $7.4B free cash flow, $164.6B market cap, and a long dividend-growth track record. With valuation compressed, technicals oversold, and near-term catalysts on the calendar, this is a disciplined long trade for investors…
Exelixis combines a durable cash-generating franchise in Cabometyx with a newly approved, potentially multi-indication next-generation asset, zanzalintinib. The balance sheet and cash flow profile give a margin of safety; positive regulatory and clinical catalysts could expand valuation. This trade idea lays out an entry, stop, and target with a ra…
Riot Platforms (RIOT) is a bitcoin mining and engineering operator that is moving toward data-center and AI infrastructure optionality. With market chatter about an executive transition at a pivotal moment for the company, improving momentum in the shares and a string of operational catalysts, we are upgrading Riot from neutral to Buy on a tactical…
Chart Industries (GTLS) trades ~1.1% below a $210 per-share Baker Hughes takeout. The company sits at the intersection of rising cryogenic demand and constrained helium supply - the so-called "blue gold" - which supports long-term structural end markets including LNG and potentially quantum computing. This trade idea recommends a measured long posi…
KeyCorp's recent operating metrics and capital profile justify a constructive stance. With EPS of $1.57 (trailing), ROE near 8.3%, manageable leverage and a dividend yielding ~3.8%, the stock looks due for a modest re-rating. This trade idea lays out a mid-term (45 trading days) long, with concrete entry, target and stop, and a set of catalysts and…
Droneshield (DRSHF) is a volatile, thinly-traded OTC play that tends to reprice on headlines and shifts in short interest. The business sits squarely in counter-drone sensors and mitigation - a market that matters in a crisis - but this stock is more of a tactical trade than a crisis-era safe haven. I lay out a mid-term (45 trading days) buy plan w…
IAC's public portfolio of content and services businesses, ~$1.7B in cash and a market cap near $3.3B suggest the market is assigning a low value to the company's operating assets. With consensus analyst targets north of $70 and several near‑term catalysts, a disciplined swing long from current levels makes sense while protecting capital with a con…
Alphabet ($GOOG) just crossed the $4 trillion market-cap threshold and remains a cash-generating pillar of the AI compute stack. Strong free cash flow ($73.3B), robust ROE (31.8%), and a bullish technical backdrop support a tactical long. Valuation is rich but not extreme vs. durable earnings power. Trade plan provided for a swing-duration opportun…
Travelers reported strong recent earnings, is boosting buybacks, and trades at reasonable multiples for a high-return insurer. Technicals show bullish momentum without overstretched indicators. We lay out an actionable swing trade with entry, stop and target and explain the fundamental and technical case.
ANTA Sports (ANPDY) looks buyable after signs of accelerating momentum and a strategic international investment. The company trades at a reasonable P/E of 15.7 on a $29.9B market cap, yields about 3.0%, and shows bullish technicals. This trade plan targets $310 over a mid-term 45 trading day window with a $245 stop to respect recent support and vol…
Utz Brands (UTZ) trades near multi-month lows with a market cap around $1.12B, cheap multiples (P/S ~0.48) and a modest dividend. That setup looks attractive for a mid-term long, but recent geopolitical-driven inflationary pressure tied to global commodity channels elevates margin risk. The trade here is tactical: buy a near-term dip with strict ri…
Amazon is priced like a mature growth compounder while still carrying structural optionality from AWS hosting and commercialization of next-gen LLM providers. With a market cap near $2.65T, attractive profitability metrics, and clear balance-sheet strength, a focused long with a disciplined stop offers asymmetric risk/reward if cloud-AI partnership…
United States Antimony (UAMY) sits at the intersection of geopolitical policy and scarce supply. With a market cap near $1.52B, bullish technicals, and multiple government- and defense-related catalysts, UAMY is a high-risk, high-reward long trade. This plan lays out an entry at $10.60, a stop at $8.50 and a target of $18.00 over a long-term (180 t…
NewAmsterdam Pharma (NAMS) is a late-stage developer of obicetrapib, an oral CETP inhibitor that materially lowers LDL-C. The stock currently trades near $33.38 with a market cap near $3.8-3.9B. With EMA decisions expected in H2 2026, meaningful trial readouts and a strong cash raise behind it, NAMS is a risk-on buy for investors willing to accept …
Barrick's decision to fully exit Canada and explore a US redomiciliation, plus talk of a North America IPO, creates an industry narrative shift that should increase retail bullion demand and lending activity at integrated precious-metals platforms. Gold.com (GOLD) looks attractively placed: $46.57 stock, implied free cash flow yield in the mid-20s,…
Technip Energies (THNPF) is showing clear technical strength while carrying extreme short interest and thin liquidity — a combination that can produce outsized moves. This trade idea targets a mid-term squeeze/momentum move with a defined entry at $42.00, stop at $37.00 and a first target at $55.00 (mid term 45 trading days). The plan balances a ta…
Ondas (ONDS) has moved from small-cap promise to an active defense contractor with material revenue growth, heavy backlog wins and a roughly $1.5B cash war chest. Valuation still reflects a growth story more than current sales; with guidance of at least $375M for 2026, the base case supports a re-rating. This trade plan buys into that re-rating wit…
We like a tactical long in Harbour Energy here. The company’s acquisition - and the implied cashflow lift - combined with technically oversold price action, manageable market capitalization ($50.6m) and elevated short interest set up a favorable mean-reversion / re-rating trade over the next 45 trading days. Entry at $11.906, stop at $10.25, target…
AST SpaceMobile has moved from speculative R&D toward commercial service. The stock is priced for growth, but the balance sheet and recent execution reduce the binary risk. We recommend a long trade at $89.00 with a $140.00 target over 180 trading days and a hard stop at $74.00.
First Trust Preferred Securities and Income ETF (FPE) yields 5.67%, is trading just below its 52-week high and shows bullish technical momentum. If the market underestimates preferreds' upside after conservative growth targets presented by the sector, FPE is a sensible mid-term trade: enter $18.10, target $18.75, stop $17.70 for a trade horizon of …
Micron's stock has ripped from a 52-week low of $65.65 to the mid-$400s, but the company's fundamentals - $10.3B in free cash flow, 33% return on equity, low leverage and sold-out memory capacity through 2026-27 - argue for further upside if AI data center demand holds. This trade idea lays out an entry at $455.00, a stop at $410.00 and a target of…
RENK Group AG (RNKGF) is an OTC-listed industrial supplier that sits squarely in the supply chain for tracked vehicles, naval propulsion and armored systems. With European defense budgets expanding, RENK looks like a pure-play supplier with improving technicals and a stretched short base. This trade idea outlines a tactical long: entry $61.00, stop…
Broadcom's pivot into custom AI accelerators and infrastructure software has pushed revenue and margins sharply higher. The stock looks expensive on headline multiples, but a string of enterprise AI deals and sizable free cash flow give a path to a near-100% upside over the next 180 trading days if execution holds. This trade idea lays out an entry…
HealthEquity (HQY) is the largest HSA custodian and has just reported another year of durable account and asset growth. With HSA assets at $36.5B, HSA investments up 26% and free cash flow near $409M, the business is generating real cash while still growing accounts. Valuation is reasonable for a high-quality financial SaaS-like business at roughly…
Hims & Hers (HIMS) is trading at an attractive junction: a peptide program under FDA review creates a binary upside while recent partnership wins and improving technical momentum reduce some execution risk. We upgrade to a long rating with a clear entry at $26.41, a $40 target over a 180-trading-day horizon, and an $18 stop — this is a high-risk, h…
